Patrick Enright, Longitude co-founder (Longitude)
As its biotechs hit the pandemic exit, Longitude raises $585M for new neuro, cancer, aging and orphan-focused fund
The years have been kind to Longitude Capital. This year, too.
A 2006 spinout of Pequot Capital, its founders started their new firm just four …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
